HealthDay - THURSDAY, Feb. 10 (HealthDay News) -- More than one-quarter of women with apparent early-stage ovarian cancer don't receive recommended lymph node biopsies to check for cancer spread, which nearly doubles these patients' risk of death, say U.S. researchers.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.